Clinical Pharmacology Details


BALSALAZIDE SODIUM


View Drug Forms

Indications & Dose:

Treatment of mild to moderate ulcerative colitis, acute attack


BY MOUTH: 


Adult: 2.25 g 3 times a day until remission occurs or for up to maximum of 12 weeks


Maintenance of remission of ulcerative colitis


BY MOUTH 


Adult: 1.5 g twice daily (max. per dose 3 g), adjusted according to response; maximum 6 g per day


CAUTIONS History of asthma


SIDE-EFFECTS Cholelithiasis


PREGNANCY Manufacturer advises avoid.


BREAST FEEDING Diarrhoea may develop in the infant. Monitor breast-fed infants for diarrhoea.


HEPATIC IMPAIRMENT Avoid in severe impairment.


RENAL IMPAIRMENT Manufacturer advises avoid in moderate to severe impairment.


 

Contraindications:

Side Effects:

Cautions:

Precautions:

Interaction:

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: